THE Pharmacy Guild of New
Zealand says it understands that the
NZ Commerce Commission - the
Kiwi equivalent of the ACCC - is also
investigating the issue of Reckitt
Benckiser’s pain-specific versions
of Nurofen which are all in fact
identical products (PD Mon).
The ACCC earlier this week
ordered that Nurofen Back Pain,
Period Pain, Migraine Pain and
Tension Headache be removed
from retail shelves in Australia.
The ruling only applies to Australia
but PGNZ ceo Lee Hohaia said in
the light of the decision “we will
be reminding members of their
obligation to provide full advice to
patients so patients understand the
cause of their pain, the appropriate
treatment and the best product
available”.
She said many patients still insist
on the targeted Nurofen products
even when told that the ibuprofen
dosage is equivalent to that of the
standard Nurofen products.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Dec 15
PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.